Attovia Therapeutics(ATTO)
SAN CARLOS, CABiotechnology
Focus: Attovia Therapeutics is a public-stage biotechnology company leveraging a proprietary biparatopic nanobody platform to develop immunology-focused therapeutics. Based in San Carlos, CA, the company is in early clinical development with three Phase 1 programs.
Profile data last refreshed 6h ago · AI intelligence enriched 2w ago
Funding Stage
PUBLIC
Open Jobs
3
Should You Work at Attovia Therapeutics?
AI assessmentAttovia is a high-risk, early-stage public biotech best suited for mission-driven scientists and operators comfortable with platform-stage uncertainty and limited near-term commercial validation.
Why Work Here
- Opportunity to contribute to differentiated nanobody technology platform with potential across multiple immunology indications.
Data completeness
4/9 — Basic
Company HealthSolid
Pipeline
Early-stage
3 total
LOE Risk
Protected
No near-term cliffs
Hiring
Stable
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Pipeline & Clinical Trials
ATTO-1091
Ulcerative Colitis (UC)Clinical Trials (1)
NCT07819799Safety, Tolerability and PK of ATTO 1091 in Healthy Adult Volunteers and Patients With Ulcerative Colitis
Phase 1Help build intelligence for Attovia Therapeutics
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.